Remiges Ventures, Inc. — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Capacity Biocapacitybio.cominDec 2022 · $35M✓ verified
Capacity Bio is a biotechnology company developing mitophagy modulators — small molecules, peptides, and nanoparticles that target mitochondrial biology to identify and clear dysfunctional mitochondria.
BiotechDeep TechLongevityPalo Alto, US
Amy Wang(PhD)Kenneth Horne(Executive Officer, Director)inDylan Morris(Director)Cristina Ghenoiu(Director)
BoardTaro Inaba(Director)inKen Horne
Co-investorsInsight PartnersRA CapitalAN Venture PartnersRDiscovery
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.